期刊文献+

微球缓释系统的突释现象及其影响因素 被引量:12

原文传递
导出
摘要 微球制剂的药物突释现象一直是难以解决的问题。突释效应造成在短时间内释放出大量的药物,使体内的血药水平陡然升高,产生不良反应。对于靶向缓释微球而言,将导致靶部位有效药物量的减少,最终削弱微球制剂的靶向作用。因此,如何有效地减少药物突释,实现药物的控制释放一直是药学工作者努力研究的课题。作者结合国内外研究报道综合介绍影响微球制剂释放性能的因素,为其进一步的应用提供相关的理论基础。
作者 龙娜 吕竹芬
出处 《中国药师》 CAS 2010年第3期421-423,共3页 China Pharmacist
  • 相关文献

参考文献20

  • 1王峰,涂家生,张钧寿,卢晶.PLGA微球控释系统的突释及其控制[J].药学进展,2003,27(3):142-146. 被引量:21
  • 2曹丰亮,席延伟,唐琳,于爱华,翟光喜.姜黄素肺靶向明胶微球的制备及性质研究[J].中药材,2009,32(3):423-426. 被引量:19
  • 3Yuan W, Wu F, Guo MY, et al. Development of protein delivery mierosphere system by a novel S/O/O/W multi-emulsion[J]. European Journal of Pharmaceutical Sciences ,2009,36:216-218.
  • 4He P,Stanley S, Illum L. Chitosan microspheres prepared by spray drying[J].International Journal of Pharmaceutics , 1999,187:53-65.
  • 5武莉,朱振峰,杨菁,孙洪范,冷希岗,宋存先,王彭延.影响微球药物释放因素的研究[J].生物医学工程与临床,2003,7(3):135-137. 被引量:6
  • 6Raman C, Berkland C, Kim K, et al. Modeling small-molecule release from PLG rnicrosphere:effect of polymer degradation and nonuniform drug distribution[J].J Controlled Release ,2005,103 ( 1 ) : 149-158.
  • 7王襄平,梅兴国.乳酸/羟基乙酸共聚物的分子量及其单体组成比例对利培酮微球性质的影响[J].中国药房,2007,18(1):38-41. 被引量:13
  • 8Sunit KS,Abdul AM, Prakash CS, et al. Formulation and in vitro evaluation of Eudragit microspheres of Stavudine[ J ]. Tropical Journal of Pharmaceutical Research ,2005,4 ( 1 ) :369-375.
  • 9Fu XD, Ping QN, Gao YL. Effects of formulation factors on encapsulation efficiency and release behaviourin vitroof huperzineh PLGA micmspheres [ J ]. J Microencapsul,2005,22( 1 ) :57-66.
  • 10Geze A, Venier-Julienne M C, Mathieu D, et al. Development of 5-iodo-2-de- oxyuridine milling process to reduce initial burst release from PLGA microparticles [ J ]. International Journal of Pharmacentics, 1999,178 (2) :257 -268.

二级参考文献51

  • 1高萍,丁平田,陈大为.注射用长效微球体外释放特性的研究进展[J].中南药学,2005,3(2):105-108. 被引量:7
  • 2赵志娟,丁红,谢茵.肺靶向阿霉素微球的制备及其特性研究[J].山西医科大学学报,2006,37(9):930-933. 被引量:5
  • 3李桃,杨帆,佃少娜,伍善广,陈颖,刘星辰,傅英梅.红霉素明胶微球制备工艺研究[J].南方医科大学学报,2006,26(12):1780-1781. 被引量:7
  • 4Wang J, Wang B M ,Schwendeman S P. Characterization of the initial burst release of a model peptide from poly(d, I-lactide-co-glycolide)microspheres[J].J Control Release 2002,82(2-3):289-307
  • 5Takenaga M, Yamaguchi Y, Kitagawa A, et al. A novel sustained-release formulation of insulin with dramatic reduction in initial rapid release[J]. J Control Release,2002,79(1-3):81-91.
  • 6Boury F, Marchais H, Proust J E,et al. Bovine serum albumin release from poly (α-hydroxy acid) microspheres: effects of polymer molecular weight and surface properties[J]. J Control Release, 1997,45(1) :75-86.
  • 7Bittner B ,Morlock M ,Koll H ,et al. Recombinant human erythropoietin(rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics[J]. Eur J Pharm Biopharm, 1998,45(3):295-305.
  • 8Kim H K,Park T O. Microencapsulation of Human Growth Hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism[J].Biotechnol Bioeng, 1999,65(6):660-667.
  • 9Jiang G, Woo B H, Kang F, et al. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly (d, 1-Lactice-co-glycolide) microsphercs[J]. J Coatrol Release,2002,79(1-3):137-145
  • 10Sandor M, Enscore D, Weston P, et al. Effect of protein molecular weight on release from micron-sized PLGA microspheres[J].J Control Release,2001,76(3):297-311

共引文献60

同被引文献128

引证文献12

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部